Renaissance Technologies - ONCOSEC MED INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ONCOSEC MED INC
ValueSharesWeighting
Q3 2022$33,000
-38.9%
67,398
-7.5%
0.00%
Q2 2022$54,000
-3.6%
72,898
+48.8%
0.00%
Q1 2022$56,000
-76.6%
48,998
-80.4%
0.00%
Q4 2021$239,000
+8.1%
249,361
+140.0%
0.00%
Q3 2021$221,000
-79.9%
103,898
-73.5%
0.00%
-100.0%
Q2 2021$1,100,000
-32.3%
391,505
+14.9%
0.00%
-50.0%
Q1 2021$1,625,000
-21.0%
340,706
+6.8%
0.00%0.0%
Q4 2020$2,057,000
+51.1%
318,906
-20.8%
0.00%
+100.0%
Q3 2020$1,361,000
+87.0%
402,722
+13.4%
0.00%0.0%
Q2 2020$728,000
+141.1%
355,053
+49.4%
0.00%
Q1 2020$302,000
-15.9%
237,583
+19.7%
0.00%
Q4 2019$359,000
+98.3%
198,519
+116.5%
0.00%
Q3 2019$181,00091,6790.00%
Other shareholders
ONCOSEC MED INC shareholders Q4 2022
NameSharesValueWeighting ↓
SALZHAUER MICHAEL 277,312$591,0000.24%
Avidity Partners Management LP 2,945,000$6,273,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 316,229$674,0000.12%
J. Goldman & Co LP 790,242$1,683,0000.08%
Sandbox Financial Partners, LLC 25,000$53,0000.04%
Virtu Financial LLC 25,166$54,0000.01%
D.A. DAVIDSON & CO. 108,500$231,0000.00%
J. Goldman & Co LP 26,300$56,0000.00%
TWO SIGMA ADVISERS, LP 361,401$770,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 49,500$105,0000.00%
View complete list of ONCOSEC MED INC shareholders